Efficient CART cell preparation method and system

Through CRISPR-Cas9 gene editing, optimization of culture medium and automation equipment, the complex and cost-effective CART cell preparation process is solved, efficient and personalized CART cell preparation and treatment are achieved, and the success rate of hematopoietic stem cell transplantation and patients are improved. Survival rate.

CN118995632AInactive Publication Date: 2024-11-22TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411105747.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The preparation process of CART cells is complex and costly, difficult to apply on a large scale, and the auxiliary therapies in hematopoietic stem cell transplantation are unstable, and standardized preparation methods are lacking.

Method used

CRISPR-Cas9 gene editing technology is used to accurately genetically transform T cells, optimized culture media and automated equipment are designed for cell isolation, culture and amplification, and combined with personalized treatment plans to improve gene editing efficiency and cell quality.

Benefits of technology

The CART cell preparation process is simplified, the yield and purity are improved, the production cost is reduced, personalized treatment is achieved, and the treatment effect and safety are significantly improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995632A_ABST
    Figure CN118995632A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of CART cell preparation, and discloses a high-efficiency CART cell preparation method which comprises the following steps: adopting a gene editing technology; optimizing the culture medium; automation is achieved; and adjuvant therapy application. The invention relates to a high-efficiency CART cell preparation method and a specific operation process and a practical application effect of CART cell adjuvant therapy application. Through an advanced gene editing technology, optimized culture conditions and a personalized treatment scheme, the yield, the purity and the treatment effect of the CART cells can be improved to the maximum extent, and a better treatment choice is provided for cancer patients; according to the efficient CART cell preparation method, the CART cell preparation process is simplified through a gene editing technology and an optimized culture medium, and the yield and the purity are improved. Large-scale preparation of CART cells is realized by using automatic equipment, and the production cost is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of CART cell preparation, and in particular relates to a highly efficient CART cell preparation and an adjuvant therapy in hematopoietic stem cell transplantation. Background Art

[0002] The technical background of CART cell preparation mainly involves the preparation process of chimeric antigen receptor T cells (CAR-T), which is a new type of precision targeted therapy for treating tumors. CART cells, or chimeric antigen receptor T cells (Chimeric Antigen Receptor T-Cell), are T cells modified by genetic engineering technology, which can express specific chimeric antigen receptors (CARs) to identify and attack tumor cells. Through genetic engineering technology, chimeric antigen receptors (CARs) that recognize tumor-specific antigens are introduced into T cells, enabling T cells to specifically recognize and attack tumor cells that express corresponding antigens; however, the preparation process of CART cells is complicated, costly, and difficult to apply on a large scale. The adjuvant therapy effect of CART cells in hematopoietic stem cell transplantation is unstable, and there is a lack of standardized preparation methods.

[0003] Through the above analysis, the problems and defects of the prior art are as follows:

[0004] (1) The preparation process of CART cells is complex, costly, and difficult to apply on a large scale.

[0005] (2) The adjuvant therapy effect of CART cells in hematopoietic stem cell transplantation is unstable, and there is a lack of standardized preparation methods. Summary of the invention

[0006] In response to the problems existing in the prior art, the present invention provides a method for preparing an efficient CART cell.

[0007] The present invention is implemented as follows: an efficient CART cell preparation system comprises the following modules:

[0008] The gene editing module uses CRISPR-Cas9 gene editing technology to precisely modify the genes of T cells and introduce a specific CAR structure, enabling them to specifically recognize and attack tumor cells;

[0009] The culture medium optimization module designs a special culture medium for the growth and expansion of CART cells, provides the nutritional factors and growth factors required by CART cells, and finds the best culture conditions through experimental screening and optimization of the culture medium formula;

[0010] The automation module integrates automation equipment to achieve fully automatic operation of cell separation, culture, amplification and gene editing during the preparation of CART cells, ensuring efficient and pollution-free CART cell preparation;

[0011] Adjuvant therapy application module, design and implement adjuvant therapy to improve the efficacy and safety of CART cell therapy, including the use of immunomodulators and the development of combination therapy plans.

[0012] Furthermore, the gene editing module includes:

[0013] CRISPR-Cas9 gene editing tool, used to precisely edit the genome of T cells and introduce specific CAR structural genes;

[0014] The gene editing condition optimization submodule is used to optimize the editing efficiency and specificity during the gene editing process. By adjusting the editing conditions and using efficient guide RNA, the success rate and accuracy of gene editing can be improved.

[0015] The gene editing verification submodule is used to verify the effect of gene editing through molecular biology technology to ensure that CART cells successfully express specific CAR structures.

[0016] Furthermore, the gene editing module uses CRISPR-Cas9 gene editing technology to perform precise gene modification on T cells and introduce a specific CAR structure to enable them to specifically recognize and attack tumor cells. The gene editing module includes the following steps:

[0017] Select a DNA sequence that targets a specific site in the T cell genome and design an effective gRNA sequence.

[0018] Select a single-chain antibody fragment (scFv) that can specifically recognize tumor cell surface antigens and select an appropriate signal transduction domain (such as CD3ζ and co-stimulatory molecules such as CD28 or 4-1BB).

[0019] T cells were isolated from the patient's peripheral blood, and CRISPR-Cas9 and CAR structures were introduced into T cells using electrofection or lentiviral / adenoviral vectors. The success rate of gene editing and the integration of CAR structures were verified by PCR and sequencing.

[0020] The culture medium optimization module designs a special culture medium for the growth and expansion of CART cells, provides the nutritional factors and growth factors required by CART cells, and finds the best culture conditions through experimental screening and optimization of the culture medium formula. The culture medium optimization module includes the following steps:

[0021] RPMI-1640 or DMEM is used as the basic culture medium, and serum, amino acids, vitamins and inorganic salts required for cell growth are added, as well as growth factors required for T cell growth and expansion, such as IL-2, IL-7 and IL-15.

[0022] Through multiple groups of experiments, different formulas were screened, cell proliferation rate, activity and CAR expression efficiency were compared, the optimal formula was selected, and the concentration of each component was further optimized.

[0023] The initial culture and expansion culture were carried out under the condition of maintaining the culture conditions at 37°C and 5% CO2, and the culture medium was replaced regularly to ensure that the cells grew under the optimal nutritional conditions.

[0024] After the expected number of cells is expanded, CART cells are collected and subjected to quality control tests, including CAR expression rate, cell activity and sterility tests, to ensure that CART cells meet clinical application standards.

[0025] Further, the culture medium optimization module comprises:

[0026] Special culture medium research and development submodule, used to design special culture medium for CART cell growth and expansion, providing necessary nutrient factors and growth factors;

[0027] The culture medium formula screening submodule screens different culture medium formulas through experiments to find the best culture conditions for the growth and expansion of CART cells;

[0028] The culture medium optimization and verification submodule is used to verify the optimized culture medium formula and ensure the effectiveness and stability of the culture medium by evaluating the growth rate, survival rate and functional activity of CART cells.

[0029] Furthermore, the automation module further comprises:

[0030] Intelligent control system, which is used to monitor and adjust various parameters in the CART cell preparation process, including temperature, pH value, oxygen concentration and nutrient concentration, etc. It collects data in real time through sensors and automatically adjusts operating parameters according to preset optimization conditions;

[0031] The data analysis and feedback module is used to analyze the data collected during the preparation process, provide real-time feedback on the preparation status, and optimize the culture and expansion conditions of CART cells through machine learning algorithms to ensure that the preparation process of each batch of CART cells achieves the best results.

[0032] Furthermore, the adjuvant therapy application module further includes:

[0033] The personalized treatment plan generation submodule is used to analyze and generate the most suitable CART cell treatment plan based on the patient's specific situation and gene expression profile using artificial intelligence algorithms, including selecting the appropriate CAR structure, optimizing gene editing strategies and culture conditions;

[0034] The treatment effect prediction and optimization submodule predicts the treatment effect and dynamically adjusts the treatment plan through big data analysis of historical treatment data and patient feedback information to ensure the safety and efficiency of CART cell therapy.

[0035] The present invention also provides a method for preparing an efficient CART cell, comprising:

[0036] Step 1, gene editing technology;

[0037] Step 2, optimizing the culture medium;

[0038] Step 3, automation;

[0039] Step 4: Application of adjuvant therapy.

[0040] Furthermore, the gene editing technology method:

[0041] Using CRISPRCas9 advanced gene editing technology, T cells are precisely genetically modified and specific CAR structures are introduced to enable them to specifically recognize and attack tumor cells;

[0042] By optimizing gene editing conditions, including editing efficiency and specificity.

[0043] Further, the optimized culture medium:

[0044] Design a special culture medium for the growth and expansion of CART cells, providing the nutritional factors and growth factors required by CART cells;

[0045] Through experimental screening and optimization of culture medium formula, the best culture conditions were found.

[0046] Further, the automated method:

[0047] Utilize automated equipment, including automated cell separators and automated cell culture systems, to automate and standardize the CART cell preparation process.

[0048] Further, the adjuvant therapy application method:

[0049] (1) Hematopoietic stem cell transplantation:

[0050] In the process of hematopoietic stem cell transplantation, combined with efficiently prepared CART cells for adjuvant therapy; CART cells can specifically attack residual tumor cells, improving the success rate of transplantation and the survival rate of patients;

[0051] Customize the type and quantity of CART cells according to the patient's specific conditions, including tumor type and immune status, to provide personalized adjuvant treatment plans;

[0052] (2) Personalized treatment.

[0053] Furthermore, the personalized treatment method:

[0054] During the CART cell preparation process, the CAR structure of the CART cell is customized according to the patient's tumor-specific antigens and immune status, enabling it to recognize and attack tumor cells.

[0055] Another object of the present invention is to provide an efficient CART cell preparation system comprising:

[0056] Gene editing module, used to perform precise genetic modification of T cells using CRISPRCas9 advanced gene editing technology;

[0057] The culture medium optimization module is used to screen and optimize the culture medium formula through experiments to find the best culture conditions;

[0058] Automation module, used to automate and standardize the CART cell preparation process using automated equipment, including automated cell separators and automated cell culture systems;

[0059] Application module for hematopoietic stem cell transplantation; personalized therapy.

[0060] Another object of the present invention is to provide a computer device, comprising a memory and a processor, wherein the memory stores a computer program, and when the computer program is executed by the processor, the processor executes the steps of the efficient CART cell preparation method.

[0061] Another object of the present invention is to provide a computer-readable storage medium storing a computer program, which, when executed by a processor, enables the processor to perform the steps of the efficient CART cell preparation method.

[0062] Another object of the present invention is to provide an information data processing terminal, which is used to implement the efficient CART cell preparation system.

[0063] In combination with the above technical solutions and the technical problems solved, the advantages and positive effects of the technical solutions to be protected by the present invention are as follows:

[0064] First, efficient CART cell preparation method:

[0065] Through gene editing technology and optimized culture medium, the CART cell preparation process is simplified and the yield and purity are improved.

[0066] Use automated equipment to achieve large-scale preparation of CART cells and reduce production costs.

[0067] Complementary therapy applications:

[0068] During hematopoietic stem cell transplantation, efficiently prepared CART cells are combined for adjuvant therapy.

[0069] The type and quantity of CART cells are customized according to the patient's specific condition and immune status to provide personalized adjuvant treatment plans.

[0070] The specific operation process and practical application effect of the efficient CART cell preparation method and CART cell adjuvant therapy application of the present invention. Through advanced gene editing technology, optimized culture conditions and personalized treatment plans, the yield, purity and treatment effect of CART cells can be maximized, providing better treatment options for cancer patients.

[0071] Second, the present invention solves several key problems in the prior art, especially in the preparation process of CART cells, improves the gene editing efficiency, optimizes the cell culture conditions, and realizes the automation and intelligent management of the preparation process. The traditional CART cell preparation method has problems such as low gene editing efficiency, unstable culture medium formula, cumbersome manual operation and easy introduction of pollution. These problems seriously limit the preparation efficiency and quality of CART cells, and thus affect its clinical application effect.

[0072] By introducing CRISPR-Cas9 gene editing technology, the present invention significantly improves the efficiency and specificity of CART cell gene modification. The optimized gene editing conditions, including the regulation of editing efficiency and specificity, enable CART cells to express specific CAR structures more quickly and accurately, improving the functionality and targeting of CART cells. At the same time, the development and optimization of special culture media provide the nutritional factors and growth factors required for CART cells. Through experimental screening and optimization of the culture medium formula, the optimal culture conditions were found, which significantly improved the growth rate and survival rate of CART cells.

[0073] The present invention also realizes the fully automatic operation of the CART cell preparation process through integrated automation equipment. All links from cell separation, culture, amplification to gene editing are carried out in a sterile and controllable environment, reducing the risk of contamination introduced by human operation and greatly improving the preparation efficiency and consistency. The introduction of the intelligent control system can monitor and adjust various parameters in the preparation process in real time, and continuously optimize the preparation conditions through data analysis and machine learning algorithms to ensure that each batch of CART cell preparation can achieve the best effect.

[0074] In addition, the adjuvant therapy application module of the present invention generates a personalized treatment plan through an artificial intelligence algorithm, combined with the patient's specific conditions and gene expression profiles, and predicts the treatment effect and dynamically adjusts the treatment plan through big data analysis of historical treatment data and patient feedback information to ensure the safety and efficiency of treatment. In summary, the present invention has made significant technological progress in the preparation and application of CART cells, not only improving the quality and preparation efficiency of CART cells, but also improving the clinical effect of CART cell therapy through intelligent and personalized program optimization. BRIEF DESCRIPTION OF THE DRAWINGS

[0075] Figure 1 It is a flow chart of the efficient CART cell preparation method provided by an embodiment of the present invention.

[0076] Figure 2 It is a flow chart of the auxiliary therapy application method provided by an embodiment of the present invention.

[0077] Figure 3 It is a structural block diagram of an efficient CART cell preparation system provided by an embodiment of the present invention.

[0078] Figure 4 The comparison of the efficiency of CART cell preparation between the traditional method and the method of the present invention is shown. The red curve represents the traditional method, and the blue curve represents the method of the present invention.

[0079] Figure 5 A comparison of the CART cell therapy effects between the traditional method and the method of the present invention is demonstrated. DETAILED DESCRIPTION

[0080] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0081] like Figure 1 As shown, an efficient CART cell preparation method provided by an embodiment of the present invention comprises the following steps:

[0082] S101, gene editing technology;

[0083] S102, optimized medium;

[0084] S103, Automation;

[0085] S104, application of adjuvant therapy.

[0086] Implementation method: Efficient CART cell preparation system

[0087] 1. System composition

[0088] This efficient CART cell preparation system includes the following main modules:

[0089] Gene editing module

[0090] Media Optimization Module

[0091] 2. Gene Editing Module

[0092] 2.1 Selection of gene editing tools

[0093] CRISPR-Cas9 gene editing technology is used to precisely modify the genes of T cells. The CRISPR-Cas9 system uses Cas9 protein and guide RNA (gRNA) to guide the targeted DNA sequence for double-stranded cutting, thereby introducing a specific CAR (chimeric antigen receptor) structure.

[0094] 2.2 gRNA design

[0095] Target sequence selection: Select a DNA sequence that targets a specific site in the T cell genome.

[0096] gRNA Design Tool: Use this online tool to design effective gRNA sequences to ensure high specificity and efficient cleavage.

[0097] 2.3CAR structure design

[0098] Antibody fragments: Select single-chain antibody fragments (scFv) that can specifically recognize tumor cell surface antigens.

[0099] Signaling domain: Select appropriate signal transduction domains (such as CD3ζ and co-stimulatory molecules such as CD28 or 4-1BB) to enhance the activation and expansion of T cells.

[0100] 2.4 Gene Editing of T Cells

[0101] T cell isolation: T cells are isolated from the patient's peripheral blood.

[0102] Electrofection or viral vector transduction: CRISPR-Cas9 and CAR constructs are introduced into T cells using electrofection or lentiviral / adenoviral vectors.

[0103] Gene editing validation: PCR and sequencing were used to verify the cutting efficiency of CRISPR-Cas9 and the successful integration of the CAR construct.

[0104] 3. Culture medium optimization module

[0105] 3.1 Screening of culture medium components

[0106] Basic ingredients: RPMI-1640 or DMEM as the basic culture medium.

[0107] Added ingredients: Add serum (such as fetal bovine serum), amino acids, vitamins and inorganic salts required for cell growth.

[0108] Growth factors: Add growth factors required for T cell growth and expansion, such as IL-2, IL-7, and IL-15.

[0109] 3.2 Optimization of culture conditions

[0110] Temperature and CO2 concentration: The culture conditions were maintained at 37°C and 5% CO2.

[0111] Frequency of medium replacement: Regularly replace the medium to ensure that cells grow under optimal nutritional conditions.

[0112] 3.3 Culture medium formulation optimization

[0113] Experimental screening: Different formulations were screened through multiple groups of experiments to compare cell proliferation rate, activity and CAR expression efficiency.

[0114] Optimize formula: Select the best formula and further optimize the concentration of each ingredient.

[0115] 3.4 Expansion and culture

[0116] Initial culture: Gene-edited T cells are inoculated into optimized culture medium for initial culture.

[0117] Expansion culture: Expand in a large-scale culture system and monitor cell density and status to ensure efficient cell proliferation.

[0118] 4. Specific implementation steps

[0119] 4.1 T cell isolation and pretreatment

[0120] T cells were isolated from the patient's peripheral blood and cultured for 48 hours in a preliminary culture medium containing basal medium and growth factors.

[0121] 4.2 Gene Editing

[0122] The designed gRNA and Cas9 protein are introduced into T cells through electrofection or viral vectors for gene editing.

[0123] During the gene editing process, a specific CAR structure is added.

[0124] 4.3 Gene Editing Verification

[0125] T cell genomic DNA was extracted, and the success rate of gene editing and the integration of CAR structure were verified by PCR amplification and sequencing.

[0126] 4.4 Cell culture and expansion

[0127] Transfer the successfully gene-edited T cells into optimized culture medium, adjust the culture conditions and perform cell expansion.

[0128] Regularly monitor the proliferation rate and activity of cells and replace the culture medium in time to ensure that the cells grow in the best condition.

[0129] 4.5 Final product collection and quality control

[0130] After expansion to the desired cell number, CART cells are collected.

[0131] Quality control tests are performed, including CAR expression rate, cell activity, and sterility tests, to ensure that CART cells meet clinical application standards.

[0132] Through the above method, this efficient CART cell preparation system can effectively realize gene editing and efficient amplification of T cells, providing high-quality CART cells for clinical tumor immunotherapy.

[0133] The embodiment of the present invention provides an efficient CART cell preparation method, which aims to significantly improve the preparation efficiency and clinical treatment effect of CART cells through advanced gene editing technology, optimized culture medium, automated operation and adjuvant therapy application. The detailed working principle of this method includes the following four main steps:

[0134] S101: Gene Editing Technology

[0135] T cells are precisely genetically modified by using CRISPR-Cas9 gene editing technology. First, T cells are isolated from the blood of patients or healthy donors. Then, specific guide RNA (sgRNA) is designed to guide the CRISPR-Cas9 system to perform precise cutting and repair in the genome of T cells, thereby introducing a specific chimeric antigen receptor (CAR) gene. This CAR gene enables T cells to specifically recognize and attack tumor cells. By optimizing gene editing conditions, including improving editing efficiency and specificity, CART cells are ensured to have efficient targeting ability and killing effect.

[0136] S102: Optimizing culture medium

[0137] Design a special culture medium for the growth and expansion of CART cells. This culture medium contains the nutrients and growth factors required by CART cells to ensure that CART cells can grow and expand rapidly in an in vitro environment. Through experimental screening and optimization of the culture medium formula, the optimal culture conditions are found, including appropriate pH, temperature, and oxygen concentration, to maximize the survival rate and proliferation ability of CART cells. In addition, by adding specific factors, such as interleukin-2 (IL-2), the activity and function of CART cells are further enhanced.

[0138] S103: Automation

[0139] Introduce automated equipment to achieve fully automatic operation of the CART cell preparation process. All aspects from cell separation, culture, amplification to gene editing are carried out in a sterile and controllable environment. The automation system includes an intelligent control system and a data analysis module, which can monitor and adjust various parameters in the preparation process (such as temperature, pH value, oxygen concentration, and nutrient concentration, etc.) in real time. The sensor collects data in real time and automatically adjusts the operating parameters according to the preset optimization conditions to ensure the efficiency and consistency of CART cell preparation and reduce the risk of contamination introduced by human operation.

[0140] S104: Application of complementary therapy

[0141] After the preparation of CART cells is completed, adjuvant therapy is designed and implemented to improve the effect and safety of CART cell therapy. Adjuvant therapy includes the use of immunomodulators and the formulation of combined treatment plans. By combining the patient's specific situation and gene expression profile, artificial intelligence algorithms are used to analyze and generate the most suitable CART cell treatment plan. Personalized treatment plans include selecting appropriate CAR structures, optimizing gene editing strategies and culture conditions. Through big data analysis of historical treatment data and patient feedback information, the treatment effect is predicted and the treatment plan is dynamically adjusted to ensure the safety and efficiency of CART cell therapy.

[0142] In summary, the efficient CART cell preparation method of the present invention realizes the efficient preparation and application of CART cells through advanced gene editing technology, optimized culture medium, automated operation and adjuvant therapy application, and significantly improves the quality of CART cells and clinical treatment effects.

[0143] The present invention provides a specific implementation example.

[0144] 1. Overall realization of efficient CART cell preparation system

[0145] 1. System construction:

[0146] Integrate gene editing module, culture medium optimization module, automation module and adjuvant therapy application module into a unified operating platform.

[0147] Ensure the smooth flow of data and information between modules to achieve collaborative work.

[0148] 2. Operation process:

[0149] A sample of T cells is collected from the patient.

[0150] The T cell sample is introduced into the gene editing module for CRISPR-Cas9 gene editing to introduce specific CAR structural genes.

[0151] The edited T cells (i.e., CART cells) are introduced into the culture medium optimization module and cultured and expanded using a dedicated culture medium.

[0152] In the automation module, automatic separation, culture, expansion and gene editing monitoring of CART cells are achieved.

[0153] The adjuvant therapy application module is responsible for the design and implementation of immunomodulatory agent use and combination therapy plans to improve the efficacy and safety of CART cell therapy.

[0154] 2. Implementation of Gene Editing Module

[0155] 1. CRISPR-Cas9 gene editing tool:

[0156] Choose an appropriate CRISPR-Cas9 system, such as SpCas9 or SaCas9.

[0157] Design and synthesize guide RNA (gRNA) targeting the gene of interest.

[0158] 2. Gene editing condition optimization submodule:

[0159] The gene editing efficiency can be optimized by adjusting the concentration of the CRISPR-Cas9 system, the concentration of gRNA, the editing time, and the temperature.

[0160] Improve the precision of gene editing using efficient guide RNA design and screening methods.

[0161] 3. Gene editing verification submodule:

[0162] Use molecular biology techniques such as PCR and sequencing to verify the effect of gene editing.

[0163] Flow cytometry and other methods are used to detect whether CART cells successfully express specific CAR structures.

[0164] 3. Implementation of Culture Medium Optimization Module

[0165] 1. Special culture medium research and development submodule:

[0166] Develop special culture medium based on the growth and expansion requirements of CART cells.

[0167] Add necessary nutrients and growth factors, such as cytokines, hormones, amino acids, etc.

[0168] 2. Culture medium formula screening submodule:

[0169] Design a variety of different culture medium formulations for preliminary screening.

[0170] By comparing the growth rate, survival rate and functional activity of CART cells under different formulations, the optimal formulation was found.

[0171] 3. Culture medium optimization and verification submodule:

[0172] Further verification and optimization are carried out based on the best formula.

[0173] Evaluate the growth rate, survival rate, and functional activity of CART cells in the optimized culture medium to ensure the effectiveness and stability of the culture medium.

[0174] 4. Automation Module Implementation

[0175] 1. Automation equipment integration:

[0176] Integrate the automation equipment required for cell isolation, culture, expansion and gene editing.

[0177] Automate and monitor operational processes.

[0178] 2. Data and information flow management:

[0179] Establish a unified data management system to record and analyze the operation data and results of each module.

[0180] Realize data and information sharing among modules to ensure efficient operation of the system.

[0181] 5. Implementation of auxiliary therapy application module

[0182] 1. Use of immunomodulators:

[0183] Select appropriate immunomodulators based on the patient's condition and the characteristics of CART cell therapy.

[0184] Develop regimens and dosages for immunomodulators.

[0185] 2. Development of combined treatment plan:

[0186] Combine CART cell therapy with other treatments (such as chemotherapy, radiotherapy, etc.) to develop a combined treatment plan.

[0187] Evaluate the efficacy and safety of combined treatment regimens to ensure optimal treatment outcomes.

[0188] The gene editing technology method provided by the embodiment of the present invention:

[0189] Using CRISPRCas9 advanced gene editing technology, T cells are precisely genetically modified and specific CAR structures are introduced to enable them to specifically recognize and attack tumor cells;

[0190] By optimizing gene editing conditions, including editing efficiency and specificity.

[0191] The optimized culture medium provided by the embodiment of the present invention is:

[0192] Design a special culture medium for the growth and expansion of CART cells, providing the nutritional factors and growth factors required by CART cells;

[0193] Through experimental screening and optimization of culture medium formula, the best culture conditions were found.

[0194] The automation method provided by the embodiment of the present invention:

[0195] Utilize automated equipment, including automated cell separators and automated cell culture systems, to automate and standardize the CART cell preparation process.

[0196] like Figure 2 As shown, the auxiliary therapy application method provided by the embodiment of the present invention is:

[0197] S201, Hematopoietic Stem Cell Transplantation:

[0198] In the process of hematopoietic stem cell transplantation, combined with efficiently prepared CART cells for adjuvant therapy; CART cells can specifically attack residual tumor cells, improving the success rate of transplantation and the survival rate of patients;

[0199] Customize the type and quantity of CART cells according to the patient's specific conditions, including tumor type and immune status, to provide personalized adjuvant treatment plans;

[0200] S202, Personalized treatment.

[0201] The personalized treatment method provided by the embodiment of the present invention is:

[0202] During the CART cell preparation process, the CAR structure of the CART cell is customized according to the patient's tumor-specific antigens and immune status, enabling it to recognize and attack tumor cells.

[0203] like Figure 3 As shown, an efficient CART cell preparation system provided by an embodiment of the present invention includes:

[0204] Gene editing module, used to perform precise genetic modification of T cells using CRISPRCas9 advanced gene editing technology;

[0205] The culture medium optimization module is used to screen and optimize the culture medium formula through experiments to find the best culture conditions;

[0206] Automation module, used to automate and standardize the CART cell preparation process using automated equipment, including automated cell separators and automated cell culture systems;

[0207] Application module for hematopoietic stem cell transplantation; personalized therapy.

[0208] The specific implementation scheme of the two modules in the embodiment of the present invention.

[0209] Culture Media Optimization Module: Design and develop specialized culture media

[0210] 1. Preliminary design: Based on the biological characteristics of CART cells, a special culture medium formula is preliminarily designed, which contains necessary basic components (such as amino acids, glucose, etc.), nutritional factors and growth factors (such as interleukin-2 (IL-2), interleukin-7 (IL-7), interleukin-15 (IL-15)).

[0211] 2. Literature research and reference: Combine existing literature and previous research results, refer to existing CART cell culture medium formulas, and optimize the preliminary design.

[0212] Experimental screening and optimization of culture medium formulation:

[0213] 1. Single factor experiment: Through single factor experiments, the effects of the concentrations of different nutritional factors and growth factors on the growth and expansion of CART cells are tested separately to find the optimal concentration range of each factor.

[0214] 2. Multifactor experiment: Based on the single-factor experiment, multifactor experimental design (such as orthogonal experimental design or response surface method) is used to study the synergistic effects of different factor combinations on the growth and expansion of CART cells and optimize the culture medium formula.

[0215] 3. Dynamic monitoring: Use a real-time cell analysis system to dynamically monitor the growth curve, survival rate, and proliferation rate of CART cells under different culture medium conditions to screen out the optimal culture conditions.

[0216] Verify the optimized culture medium:

[0217] 1. Multi-batch verification: Under the optimized culture medium conditions, multiple batches of CART cell culture experiments are carried out to verify the stability and repeatability of the culture medium.

[0218] 2. Functional evaluation: Through cytotoxicity experiments, cell activity detection and specific killing experiments, the functionality of CART cells cultured under optimized culture medium conditions is evaluated to ensure that they have efficient tumor killing ability.

[0219] Automation module: integrated automation equipment

[0220] 1. Automated cell separation system: Use fully automatic cell separation equipment to separate T cells from the blood of patients or healthy donors through immunomagnetic bead sorting or flow cytometry sorting technology.

[0221] 2. Automated culture system: Use automated cell culture equipment equipped with precise temperature control system, gas control system and automatic culture medium replacement system to achieve sterile culture and expansion of CART cells.

[0222] Automated gene editing system:

[0223] 1. Automated gene editing platform: Integrates CRISPR-Cas9 gene editing technology and automatically introduces the designed sgRNA and Cas9 protein into T cells through high-throughput transfection equipment for gene editing operations.

[0224] 2. Gene editing verification system: Through an automated molecular biology detection platform, using technologies such as PCR, sequencing and flow cytometry, the efficiency and specificity of gene editing are automatically verified.

[0225] Intelligent control and data analysis system:

[0226] 1. Intelligent control system: Use sensors and controllers to monitor parameters such as temperature, pH value, oxygen concentration, and nutrient concentration of the cell culture environment in real time, and automatically adjust operating parameters according to preset optimization conditions to ensure the efficiency and consistency of CART cell preparation.

[0227] 2. Data analysis and feedback system: Integrate data acquisition and analysis modules, collect and analyze data during the culture process in real time, use machine learning algorithms for data modeling and analysis, optimize culture conditions and gene editing strategies, and improve the success rate and efficiency of CART cell preparation.

[0228] Process Automation:

[0229] 1. Integrated process design: Integrate all aspects of cell separation, culture, amplification and gene editing into an automated workstation, and achieve seamless connection through robotic arms and automated transmission systems, reduce manual intervention and reduce contamination risks.

[0230] 2. Operation interface optimization: Design a user-friendly operation interface, simplify the operation process, provide real-time monitoring and alarm functions, and ensure the simplicity and safety of operation.

[0231] Through the specific implementation scheme of the above-mentioned culture medium optimization and automation module, the present invention can significantly improve the efficiency and quality of CART cell preparation. The optimized culture medium provides the optimal nutrition and environmental conditions required for the growth and expansion of CART cells. The automated equipment and intelligent control system ensure the efficiency, pollution-free and consistency of the CART cell preparation process, and ultimately achieve the preparation of efficient CART cells and improve their clinical application effects.

[0232] Another object of the present invention is to provide a computer device, comprising a memory and a processor, wherein the memory stores a computer program, and when the computer program is executed by the processor, the processor executes the steps of the efficient CART cell preparation method.

[0233] Another object of the present invention is to provide a computer-readable storage medium storing a computer program, which, when executed by a processor, enables the processor to perform the steps of the efficient CART cell preparation method.

[0234] Another object of the present invention is to provide an information data processing terminal, which is used to implement the efficient CART cell preparation system.

[0235] The present invention is specifically implemented:

[0236] 1. Efficient CART cell preparation method:

[0237] Through gene editing technology and optimized culture medium, the CART cell preparation process is simplified and the yield and purity are improved.

[0238] Use automated equipment to achieve large-scale preparation of CART cells and reduce production costs.

[0239] 2. Application of auxiliary therapy:

[0240] During hematopoietic stem cell transplantation, efficiently prepared CART cells are combined for adjuvant therapy.

[0241] The type and quantity of CART cells are customized according to the patient's specific condition and immune status to provide personalized adjuvant treatment plans.

[0242] Regarding the specific implementation of efficient CART cell preparation methods and adjuvant therapy applications, we can discuss in detail from the following aspects:

[0243] Highly efficient CART cell preparation method

[0244] 1. Gene Editing Technology:

[0245] Using advanced gene editing technologies such as CRISPRCas9, T cells are precisely genetically modified and specific CAR (chimeric antigen receptor) structures are introduced to enable them to specifically recognize and attack tumor cells.

[0246] The yield and purity of CART cells can be improved by optimizing gene editing conditions, such as editing efficiency and specificity.

[0247] 2. Optimize the culture medium:

[0248] A special culture medium is designed for the growth and expansion of CART cells, which provides the nutritional factors and growth factors required by CART cells and promotes rapid cell expansion and activity maintenance.

[0249] Through experimental screening and optimization of culture medium formula, the optimal culture conditions are found to improve the yield and quality of CART cells.

[0250] 3. Automation equipment:

[0251] Utilize automated equipment, such as automated cell separators and automated cell culture systems, to automate and standardize the CART cell preparation process.

[0252] The application of automated equipment can greatly improve the preparation efficiency and consistency of CART cells, and reduce production costs and human operation errors.

[0253] Adjunctive therapy application

[0254] 1. Hematopoietic stem cell transplantation:

[0255] In the process of hematopoietic stem cell transplantation, the highly efficiently prepared CART cells are combined for adjuvant therapy. CART cells can specifically attack residual tumor cells, improving the success rate of transplantation and the survival rate of patients.

[0256] The type and quantity of CART cells are customized according to the patient's specific conditions, such as tumor type, immune status, etc., to provide personalized adjuvant treatment plans.

[0257] 2. Personalized treatment:

[0258] During the CART cell preparation process, the CAR structure of the CART cell is customized according to the patient's tumor-specific antigens and immune status, enabling it to more accurately identify and attack tumor cells.

[0259] Through personalized treatment, the efficacy of CART cells can be maximized while reducing unnecessary side effects and risks.

[0260] In summary, efficient CART cell preparation methods and adjuvant therapy applications need to be achieved by combining advanced gene editing technology, optimized culture medium formulations, and automated equipment. In terms of adjuvant therapy applications, personalized treatment is required based on the patient's specific circumstances to improve treatment efficacy and patient survival rates.

[0261] Technical effects:

[0262] 1. The efficient CART cell preparation method significantly reduces the preparation cost, improves the yield and purity, and makes CART cell therapy more feasible and economical.

[0263] 2. Standardized preparation methods and automated equipment improve the consistency and reliability of CART cell preparation.

[0264] 3. Combined with CART cell adjuvant therapy, the success rate of hematopoietic stem cell transplantation and the survival rate of patients are improved, and the treatment effect of patients with blood diseases is significantly improved.

[0265] When it comes to specific embodiments to illustrate the highly efficient CART cell preparation method and adjuvant therapy application, the following two examples can be provided based on the information in the reference articles and related practices:

[0266] Example 1: Method for preparing highly efficient CART cells

[0267] 1. T cell collection and separation:

[0268] T cell samples are collected from the patient's peripheral blood.

[0269] Pure T cells are isolated from the collected samples using flow cytometry or other cell separation techniques.

[0270] 2. Genetic modification:

[0271] Using gene editing technologies such as CRISPRCas9, specific CAR gene sequences are precisely inserted into T cells, causing them to express CAR proteins that can recognize and attack tumor cells.

[0272] This step is achieved through an automated transduction system to ensure the efficiency and accuracy of genetic modification.

[0273] 3. In vitro culture and expansion:

[0274] The genetically modified T cells were placed into GREX culture flasks and culture medium containing appropriate growth factors and activators was added.

[0275] Static culture in a closed CO2 incubator eliminates the need for frequent fluid changes or shaking, reducing operations and contamination risks.

[0276] Synthetic peptides such as Vectofusin1 are used to enhance viral transduction efficiency and improve the yield and purity of CART cells.

[0277] 4. Screening and purification:

[0278] Use flow cytometry or other cell separation techniques to screen out CART cells expressing CAR protein and remove other cell impurities.

[0279] Ensure the purity and activity of CART cells and prepare for subsequent storage and treatment.

[0280] Example 2: Application of CART cell-assisted therapy

[0281] 1. Personalized treatment plan formulation:

[0282] The CAR structure of CART cells is customized according to the patient's tumor type and immune status, enabling them to specifically recognize and attack tumor cells.

[0283] Develop personalized CART cell therapy dosage and administration plan to ensure treatment efficacy and patient safety.

[0284] 2.CART cell infusion:

[0285] Combined with CART cells for adjuvant therapy during hematopoietic stem cell transplantation or other immunotherapy.

[0286] The prepared CART cells are returned to the patient's body through intravenous infusion to allow them to target and attack tumor cells.

[0287] 3. Efficacy monitoring and adjustment:

[0288] After CART cell therapy, the patient's tumor markers, immune status and other indicators are monitored regularly to evaluate the treatment effect.

[0289] According to the efficacy monitoring results, the dosage and administration regimen of CART cells will be adjusted in time to ensure continuous optimization of the treatment effect.

[0290] These two examples respectively demonstrate the specific operation process and actual application effect of the efficient CART cell preparation method and CART cell adjuvant therapy application. Through advanced gene editing technology, optimized culture conditions and personalized treatment plans, the yield, purity and therapeutic effect of CART cells can be maximized, providing better treatment options for cancer patients.

[0291] Comparison of CART cell preparation efficiency:

[0292] Figure 4 The comparison between the traditional method and the method of the present invention in terms of CART cell preparation efficiency is shown. The red curve represents the traditional method, and the blue curve represents the method of the present invention. The method of the present invention significantly improves the preparation efficiency of CART cells through gene editing technology and culture medium optimization.

[0293] Comparison of CART cell therapy effects:

[0294] Figure 5 The comparison between the traditional method and the method of the present invention in terms of the therapeutic effect of CART cells is shown. The green curve represents the traditional method, and the purple curve represents the method of the present invention. The method of the present invention significantly improves the therapeutic effect of CART cells through intelligent control and optimization of personalized treatment plans.

[0295] These graphs clearly show that the present invention has achieved significant technological progress in CART cell preparation efficiency and therapeutic effect, and can provide more efficient and effective support for clinical treatment.

[0296] The above description is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Any modifications, equivalent substitutions and improvements made by any technician familiar with the technical field within the technical scope disclosed by the present invention and within the spirit and principle of the present invention should be covered by the protection scope of the present invention.

Claims

1. An efficient CART cell preparation system, characterized in that: Includes the following modules: The gene editing module uses CRISPR-Cas9 gene editing technology to precisely modify the genes of T cells and introduce a specific CAR structure, enabling them to specifically recognize and attack tumor cells; The culture medium optimization module designs a special culture medium for the growth and expansion of CART cells, provides the nutritional factors and growth factors required by CART cells, and finds the best culture conditions through experimental screening and optimization of the culture medium formula; The automation module integrates automation equipment to achieve fully automatic operation of cell separation, culture, amplification and gene editing during the preparation of CART cells, ensuring efficient and pollution-free CART cell preparation; Adjuvant therapy application module, design and implement adjuvant therapy to improve the efficacy and safety of CART cell therapy, including the use of immunomodulators and the development of combination therapy plans.

2. The efficient CART cell preparation system according to claim 1, characterized in that The gene editing module uses CRISPR-Cas9 gene editing technology to perform precise genetic modification on T cells and introduce a specific CAR structure to enable them to specifically recognize and attack tumor cells. The gene editing module includes the following steps: selecting a DNA sequence that targets a specific site in the T cell genome and designing an effective gRNA sequence; selecting a single-chain antibody fragment (scFv) that can specifically recognize tumor cell surface antigens and selecting a suitable signal transduction domain (such as CD3ζ and co-stimulatory molecules such as CD28 or 4-1BB); Isolate T cells from the patient's peripheral blood, introduce CRISPR-Cas9 and CAR structures into T cells using electroporation or lentiviral / adenoviral vectors, and verify the success rate of gene editing and the integration of CAR structures by PCR and sequencing; The culture medium optimization module designs a special culture medium for the growth and expansion of CART cells, provides the nutritional factors and growth factors required for CART cells, and finds the best culture conditions through experimental screening and optimization of the culture medium formula. The culture medium optimization module includes the following steps: using RPMI-1640 or DMEM as the basic culture medium, adding serum, amino acids, vitamins and inorganic salts required for cell growth, and adding growth factors required for T cell growth and expansion, such as IL-2, IL-7 and IL-15; screening different formulas through multiple groups of experiments, comparing cell proliferation rate, activity and CAR expression efficiency, selecting the optimal formula, and further optimizing the concentration of each component; performing preliminary culture and expansion culture while maintaining the culture conditions at 37°C and 5% CO2, and regularly changing the culture medium to ensure that the cells grow under the best nutritional conditions; after the expansion reaches the expected number of cells, collecting the CART cells and performing quality control tests, including CAR expression rate, cell activity and sterility tests, to ensure that the CART cells meet the clinical application standards.

3. The efficient CART cell preparation system according to claim 1, characterized in that The gene editing module comprises: CRISPR-Cas9 gene editing tool, used to precisely edit the genome of T cells and introduce specific CAR structural genes; The gene editing condition optimization submodule is used to optimize the editing efficiency and specificity during the gene editing process. By adjusting the editing conditions and using efficient guide RNA, the success rate and accuracy of gene editing can be improved. The gene editing verification submodule is used to verify the effect of gene editing through molecular biology technology to ensure that CART cells successfully express specific CAR structures.

4. The efficient CART cell preparation system according to claim 1, characterized in that The culture medium optimization module comprises: Special culture medium research and development submodule, used to design special culture medium for CART cell growth and expansion, providing necessary nutrient factors and growth factors; The culture medium formula screening submodule screens different culture medium formulas through experiments to find the best culture conditions that are most suitable for the growth and expansion of CART cells; The culture medium optimization and verification submodule is used to verify the optimized culture medium formula and ensure the effectiveness and stability of the culture medium by evaluating the growth rate, survival rate and functional activity of CART cells.

5. The efficient CART cell preparation system according to claim 1, characterized in that The automation module further comprises: Intelligent control system, which is used to monitor and adjust various parameters in the CART cell preparation process, including temperature, pH value, oxygen concentration and nutrient concentration, etc. It collects data in real time through sensors and automatically adjusts operating parameters according to preset optimization conditions; The data analysis and feedback module is used to analyze the data collected during the preparation process, provide real-time feedback on the preparation status, and optimize the culture and expansion conditions of CART cells through machine learning algorithms to ensure that the preparation process of each batch of CART cells achieves the best results.

6. The efficient CART cell preparation system according to claim 1, characterized in that The adjuvant therapy application module further includes: The personalized treatment plan generation submodule is used to analyze and generate the most suitable CART cell treatment plan based on the patient's specific situation and gene expression profile using artificial intelligence algorithms, including selecting the appropriate CAR structure, optimizing gene editing strategies and culture conditions; The treatment effect prediction and optimization submodule predicts the treatment effect and dynamically adjusts the treatment plan by performing big data analysis on historical treatment data and patient feedback information to ensure the safety and efficiency of CART cell therapy.

7. A method for preparing highly efficient CART cells, characterized in that: The highly efficient CART cell preparation method comprises the following steps: Step 1, gene editing technology; Step 2, optimizing the culture medium; Step 3, automation; Step 4: Application of adjuvant therapy.

8. The method for preparing highly efficient CART cells according to claim 7, characterized in that: The gene editing technology method: Using CRISPRCas9 advanced gene editing technology, T cells are precisely genetically modified and specific CAR structures are introduced to enable them to specifically recognize and attack tumor cells; By optimizing gene editing conditions, including editing efficiency and specificity.

9. The method for preparing highly efficient CART cells according to claim 1, characterized in that: The optimized culture medium: Design a special culture medium for the growth and expansion of CART cells, providing the nutritional factors and growth factors required by CART cells; Find the best culture conditions through experimental screening and optimization of culture medium formula; The automation method: utilizes automated equipment, including an automated cell separator and an automated cell culture system, to achieve automation and standardization of the CART cell preparation process; The adjuvant therapy application method: (1) Hematopoietic stem cell transplantation: In the process of hematopoietic stem cell transplantation, combined with efficiently prepared CART cells for adjuvant therapy; CART cells can specifically attack residual tumor cells, improving the success rate of transplantation and the survival rate of patients; Customize the type and quantity of CART cells according to the patient's specific conditions, including tumor type and immune status, to provide personalized adjuvant treatment plans; The personalized treatment approach: During the CART cell preparation process, the CAR structure of the CART cell is customized according to the patient's tumor-specific antigens and immune status, enabling it to recognize and attack tumor cells.

10. An efficient CART cell preparation system for implementing the efficient CART cell preparation method according to any one of claims 1 to 6, characterized in that: The efficient CART cell preparation system comprises: Gene editing module, used to perform precise genetic modification of T cells using CRISPRCas9 advanced gene editing technology; The culture medium optimization module is used to screen and optimize the culture medium formula through experiments to find the best culture conditions; Automation module, used to automate and standardize the CART cell preparation process using automated equipment, including automated cell separators and automated cell culture systems; Application module for hematopoietic stem cell transplantation; personalized therapy.